---
schema_version: "secwatch.filing_event.v1"
accession: "0001722482-25-000013"
form_type: "8-K"
ticker: "AVTR"
cik: "0001722482"
company_name: "Avantor, Inc."
filed_at: "2025-02-07T23:59:59+00:00"
generated_at: "2026-05-27T00:57:48.222751+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Avantor Q4 organic growth 1%, adjusted EPS $0.27; full-year adjusted EPS $0.99

## Summary
- Q4 net sales $1.69B, down 2% reported; organic growth 1% with bioprocessing up high-single digits.
- Q4 GAAP EPS $0.73 (net income $500.4M); adjusted EPS $0.27; adjusted EBITDA margin 18.2%.
- Full-year net sales $6.78B, down 3% reported; organic decline 2%; adjusted EBITDA $1.20B margin 17.7%.
- Free cash flow Q4 $222.1M; full-year $768.3M; adjusted net leverage 3.2x as of Dec 31, 2024.
- Bioscience Production segment Q4 net sales up 4% organic; Laboratory Solutions down 1% organic.

## SEC filing metadata
- accession: 0001722482-25-000013
- form_type: 8-K
- ticker: AVTR
- cik: 0001722482
- company_name: Avantor, Inc.
- filed_at: 2025-02-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1722482/000172248225000013/0001722482-25-000013-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1722482/000172248225000013/avtr-20250207.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001722482-25-000013
- JSON: https://secwatch.observer/filing/0001722482-25-000013.json
- Plain text: https://secwatch.observer/filing/0001722482-25-000013.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.